Printer Friendly

AnandaCor: Concept and feasibility assessment for AnandaCor, a fast melting tablet, as a diagnostic device in ischemic heart conditions.

EU contribution: EUR 50 000

Objective: Ouabain is a plant derived active pharmaceutical ingredient for specific heart diseases. In nanomolar doses the substance protects cardiomyocytes by stabilizing the Na+/K+ -ATPase. Ouabain enables ischemic preconditioning and has a balancing effect on the energy metabolism of cardiomyocytes by enhancing the turnover of lactate to ATP. Compared to similar substances this feature is unique to ouabain. It is also the fastest working of all cardiac glycosides, with a significantly different mode of action and a larger therapeutic range which means a smaller risk for unwanted side effects.

Ouabain targets mainly on the small vessels and the myocardial cell, rather than on the large vessels, and therefore can be useful to distinguish between relevant obstructive coronary atherosclerosis and the actual ischemia in the microvasculature or in the myocardial cell itself. These properties convey the great potential as a new diagnostic medical device for patients with angina pectoris due to ischemic heart conditions.

Therefore Ananda Pharma GmbH developed AnandaCorA, a fast melting tablet formulation of the active substance ouabain.Since cardiovascular and ischemic heart conditions are highly prevalent in all industrialized countries, with over 2 million deaths per year and estimated external costs of nearly 110 billion per annum in the European Union alone, there is an urgent need for effective diagnostic investigation.

Project completion date : 2016-01-01 12:00:00

Major organization : ANANDA PHARMA GMBH

Address : Karl-Liebknecht-StraE-e 94,

14482 Potsdam

Country :Germany

Financier : European Union (EU),

Financier address : European Union (EU)

Rue de la Loi 200/Wetstraat 200,

B-1049 Bruxelles/Brussels,

Belgium

Tel: 32-2-2999696, 2993085

Fax: 32-2-2961749

Url: ec.europa.eu/

2015 Al Bawaba (Albawaba.com) Provided by SyndiGate Media Inc. ( Syndigate.info ).

COPYRIGHT 2015 SyndiGate Media Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2015 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Mena Report
Date:Jul 7, 2015
Words:279
Previous Article:BlindShell: BlindShell - making smart phones accessible for the visually impaired.
Next Article:DISCO: Data Integrated Supply Chain Optimisation.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters